Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nan Tang

Showing results (401-410 of 408) with videos related to

Pageof 41
Sort By:
You have reached the last page of results.This site can display upto 408 results.
European Journal of Nuclear Medicine and Molecular Imaging|January 9, 2021
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CTBei-Bei Xiao, Da-Feng Lin, Xue-Song Sun, et al.
Oncoimmunology|December 15, 2018
Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trialsJonathan G Pol, Sergio A Acuna, Beta Yadollahi, et al.
International Journal of Biological Sciences|February 13, 2023
Crosstalk between PML and p53 in response to TGF-β1: A new mechanism of cardiac fibroblast activationDi Huang, Dan Zhao, Ming Li, et al.
Journal of Cancer|November 19, 2019
The impact of Adult Comorbidity Evaluation-27 on the clinical outcome of elderly nasopharyngeal carcinoma patients treated with chemoradiotherapy or radiotherapy: a matched cohort analysisYue-Feng Wen, Xue-Song Sun, Li Yuan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2022
Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority TrialXiao-Yun Li, Dong-Hua Luo, Ling Guo, et al.
Journal of Thoracic Disease|November 13, 2025
Differences in pulmonary nodular consolidation features among drug-sensitive pulmonary tuberculosis and multidrug/extensively-resistant pulmonary tuberculosis: a multi-national multi-center studySheng-Nan Tang, Xi-Ling Huang, Alena Skrahina, et al.
Journal of Thoracic Disease|March 12, 2026
Differences in pulmonary cavity features among drug-sensitive pulmonary tuberculosis and multidrug/extensively-resistant pulmonary tuberculosis: a multi-national multi-center computed tomography-based studySheng-Nan Tang, Xi-Ling Huang, Alena Skrahina, et al.
The Lancet. Oncology|March 5, 2018
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trialLin-Quan Tang, Dong-Ping Chen, Ling Guo, et al.
Pageof 41

Showing results (401-410 of 408) with videos related to

Sort By:
Pageof 41
You have reached the last page of results.This site can display upto 408 results.
European Journal of Nuclear Medicine and Molecular Imaging|January 9, 2021
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CTBei-Bei Xiao, Da-Feng Lin, Xue-Song Sun, et al.
Oncoimmunology|December 15, 2018
Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trialsJonathan G Pol, Sergio A Acuna, Beta Yadollahi, et al.
International Journal of Biological Sciences|February 13, 2023
Crosstalk between PML and p53 in response to TGF-β1: A new mechanism of cardiac fibroblast activationDi Huang, Dan Zhao, Ming Li, et al.
Journal of Cancer|November 19, 2019
The impact of Adult Comorbidity Evaluation-27 on the clinical outcome of elderly nasopharyngeal carcinoma patients treated with chemoradiotherapy or radiotherapy: a matched cohort analysisYue-Feng Wen, Xue-Song Sun, Li Yuan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2022
Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority TrialXiao-Yun Li, Dong-Hua Luo, Ling Guo, et al.
Journal of Thoracic Disease|November 13, 2025
Differences in pulmonary nodular consolidation features among drug-sensitive pulmonary tuberculosis and multidrug/extensively-resistant pulmonary tuberculosis: a multi-national multi-center studySheng-Nan Tang, Xi-Ling Huang, Alena Skrahina, et al.
Journal of Thoracic Disease|March 12, 2026
Differences in pulmonary cavity features among drug-sensitive pulmonary tuberculosis and multidrug/extensively-resistant pulmonary tuberculosis: a multi-national multi-center computed tomography-based studySheng-Nan Tang, Xi-Ling Huang, Alena Skrahina, et al.
The Lancet. Oncology|March 5, 2018
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trialLin-Quan Tang, Dong-Ping Chen, Ling Guo, et al.
Pageof 41